Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (5y) (2014 - 2018)
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (5y) (2014 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -51.50% |
| Dec 31, 2017 | -3.01% |
| Sep 30, 2017 | -6.59% |
| Jun 30, 2017 | 42.17% |
| Mar 31, 2017 | -75.23% |
| Dec 31, 2016 | -59.51% |
| Sep 30, 2016 | -22.65% |
| Jun 30, 2016 | 16.30% |
| Mar 31, 2016 | -3.51% |
| Dec 31, 2015 | 1.37% |
| Sep 30, 2015 | 13.67% |
| Jun 30, 2015 | 1.85% |
| Mar 31, 2015 | 1.63% |
| Dec 31, 2014 | -0.35% |
| Sep 30, 2014 | 9.80% |
| Jun 30, 2014 | 5.61% |
| Mar 31, 2014 | 14.30% |